Delivery Order SPE2DB24D2106-SPE2DB25FAVZK
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $3.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,708.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Ondansetron HCL 4 mg tablets (30-count units). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, operates under a firm fixed-price structure with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,329.18 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor without a set-aside designation. The place of performance is...
- The Defense Logistics Agency awarded a $8,789.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ondansetron HCl 4 mg tablets (500 count). The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.19 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 8 mg tablets (30-count packages) under a firm fixed-price contract type. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will be executed from Conshohocken, Pennsylvania. This delivery order was not issued under a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a ceiling value of $2,388.64. This firm fixed-price delivery order represents a continuation of the companies' established relationship under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million and extending through November 2026. The contract involves no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,615.21 firm fixed-price delivery order is for the provision of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,758.80 contract is for the delivery of ondansetron orally disintegrating tablets, 8 mg, in 30-count packages. DMS Pharmaceutical Group holds a larger indefinite delivery/indefinite quantity (ID/IQ) contract, number 4600082013, with the Defense Logistics Agency under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,814.73 on July 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) to support federal healthcare operations. This firm fixed-price delivery order carries an ultimate completion date of July 8, 2025, and does not utilize a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,280.16 firm fixed-price contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $3,034.47, is for Ondansetron HCL 4 mg tablets in a 30-count package. The order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm...